As a first step towards developing a more effective vaccine, CCfV is conducting a human challenge trial in Halifax to study how the whooping cough disease progresses. You may be able to help.
Four Dalhousie researchers will share new funding from the Canadian Foundation for Innovation and Research Nova Scotia for the acquisition of state-of-the-art equipment and resources.
Today@Dal is a service of Dalhousie Communications, Marketing and Creative Services. It is linked with both Dal News and the university Events Calendar.
To subscribe to the daily newsletter, send an email to listserv@lists.dal.ca containing the message: sub dal-news firstname lastname. Or subscribe from our website.
To unsubscribe, email listserv@lists.dal.ca containing the message: unsub dal-news. If you are forwarding to another email service, please include your NetID in the body copy, or else the automated subscription system will not work properly.
